Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva relocates headquarters in Israel
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceutical in $4.35 opioid settlement with states, Native American tribes (TEVA) | Seeking Alpha
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma
Teva sells Overland Park business segment - Kansas City Business Journal
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical's Sales Slump 18% - WSJ
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
FDA Requests More Data on Potential New Treatment for Huntington Disease
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Teva_Pharmaceuticals | ערוץ 7
Israel's Teva gives upbeat outlook as restructuring proceeds
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva looks to amp up research collaborations, CEO says
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva taps former Biogen exec Richard Francis as CEO - News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
